Sign in

NCT07428954Completed

Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care

A Multi-Reader Multi-Case Study for Evaluating the Impact of Legit.Health Plus Device on the Healthcare Practitioners' Assessment of Skin Lesions

Source: ClinicalTrials.gov · Last updated 24 Feb 2026

Brief summary (registry, in English)

This study aims to determine if an artificial intelligence (AI) medical device can help doctors more accurately identify a wide variety of skin conditions and improve the efficiency of patient consultations. While many patients visit primary care for skin issues, general doctors may sometimes have different opinions from specialists, which can lead to delays in getting the right treatment. The researchers hypothesized that using the AI tool would increase the true diagnostic accuracy of healthcare professionals for multiple skin conditions. To test this, 16 doctors (including 10 general practitioners and 6 dermatologists) evaluated 29 different medical images. For each case, the doctors followed a structured process: * Initial Assessment: Doctors first gave a diagnosis based only on the patient's image and medical history. * AI Support: Doctors were then shown the AI's top five suggested diagnoses and confidence levels to see if they wished to adjust their final decision. * Clinical Utility: Doctors also indicated if the patient required a specialist referral and if the case could be handled through a remote (online) consultation. The primary question the study tried to answer was whether AI support could significantly improve correct diagnoses across 13 different types of skin pathologies-ranging from common rashes to skin cancer-while also making the consultation process faster and more effective for both doctors and patients.

Status (registry)
Completed
Study type
Observational
Enrollment
16 (actual)
First submitted
18 Feb 2026
Start date
1 Jun 2024
Primary completion date
10 Oct 2024
Lead sponsor
AI Labs Group S.L
NCT number
NCT07428954

What you commit to

  • Study type: Observational
  • Participants enrolled: 16
  • From 1 Jun 2024 to the primary completion date, 10 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Low-quality images of patients which can not be properly analyzed.

Who the study is looking for

  • Board-certified primary care practitioners and dermatologists, regardless of their professional experience.
  • High-quality images of patients with different skin conditions.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AI Labs Group S.L.
Coordinator of this site? Confirm its status
BilbaoSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.